Amy E. Herr

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Minneapolis, MN
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Andrew Nick as Attorney-in-Fact for Amy E. Herr pursuant to Power of Attorney previously filed
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Amy E. Herr

Form 4 holding Director

BIO-TECHNE Corp

Security class
Stock Option (Right to Buy)
Shares / value
3,777
Estimated value
$270,546
Report date
17 Aug 2026
Price
$71.63
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,777
Form 4 holding Director

BIO-TECHNE Corp

Security class
Stock Option (Right to Buy)
Shares / value
2,735
Estimated value
$195,908
Report date
17 Aug 2026
Price
$71.63
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
2,735
Form 4 holding Director

BIO-TECHNE Corp

Security class
Restricted Stock Units
Shares / value
1,381
Estimated value
$98,921
Report date
17 Aug 2026
Price
$71.63
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
1,381

Insider Reports Filed by Amy E. Herr

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .